Insurers face long road, high cost to cover obesity drugs after promising Wegovy heart health dataCNBC • 08/09/23
Eli Lilly Has A Big Stake In Weight Loss And Alzheimer's Drugs; But Is The Stock A Buy?Investors Business Daily • 08/09/23
Eli Lilly CEO on meeting demand for expected obesity drug Mounjaro: 'It's my top priority'CNBC • 08/09/23
A new class of weight loss drugs is powering massive stock-market gains for Novo Nordisk and Eli LillyBusiness Insider • 08/08/23
Novo Nordisk, Eli Lilly Break Out As New Evidence Bolsters Weight-Loss DrugsInvestors Business Daily • 08/08/23
Lilly Stock Rockets After Diabetes Powerhouse Mounjaro Drives Beat And RaiseInvestors Business Daily • 08/08/23
Eli Lilly raises full-year guidance as drug pipeline drives second-quarter profit up 85%CNBC • 08/08/23
Eli Lilly stock shoots up into record territory after earnings beat, a big increase in the full-year outlookMarket Watch • 08/08/23
Lilly Reports Second-Quarter 2023 Financial Results, Highlights Accelerating Revenue Growth and Key Pipeline AdvancementsPRNewsWire • 08/08/23